Search

Qin Jiang

from Las Cruces, NM
Age ~62
Get Report
Also known as:
Qin Jiang Yan, Jiang Y Qin, Yan Q Jiang, Jiang Yan Qin, Yan Qin Jiang, Jiang Yan, Qin Jiang Yanqin, Yanqin Jiang
Related to:
Jiang Min, 69Xiumin JiangLin YanXing Hui YangRi H Jiang, 35Jingui Jiang, 41Jie Jiang, 54Feng Jiang Shao, 53Duan Ren Chen, 51Dian C Jiang, 61Yan Q Jiang
Connected to:
Abby H Jiang, 51Audrey W Jiang, 32Baofeng F Jiang, 57Barbara F Jiang, 33Bingyan Jiang, 62Bo Jiang, 76Boni Jiang, 50Catherine C Jiang, 62Chenqian Jiang, 40Chongjun Jiang, 57

Qin Jiang Phones & Addresses

  • Las Cruces, NM
  • New York, NY
  • Corydon, IN
  • Brooklyn, NY

Education

School / High School: London School of Economics

Ranks

Licence: New York - Currently registered Date: 2006

Professional Records

Medicine Doctors

Qin Jiang Photo 1

Qin Li Jiang

View page
Specialties:
Neurology
Work:
University Of Illinois At Chicago Neuro Rehabilitation Center
1801 W Taylor St STE 4E, Chicago, IL 60612
(312) 996-6496 (phone), (312) 996-4169 (fax)

Jesse Brown VA Medical Center Neurology
820 S Damen Ave RM 2354, Chicago, IL 60612
(312) 569-8387 (phone)
Education:
Medical School
Medical University of South Carolina College of Medicine
Graduated: 2003
Procedures:
Neurological Testing
Pulmonary Function Tests
Sleep and EEG Testing
Conditions:
Epilepsy
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Peripheral Nerve Disorders
Dementia
Languages:
English
Spanish
Description:
Dr. Jiang graduated from the Medical University of South Carolina College of Medicine in 2003. She works in Chicago, IL and 1 other location and specializes in Neurology. Dr. Jiang is affiliated with University Of Illinois Hospital Health & Science Center.

Lawyers & Attorneys

Qin Jiang Photo 2

Qin Jiang - Lawyer

View page
Address:
Hogan Lovells International LLP
(216) 122-3800 (Office)
Licenses:
New York - Currently registered 2006
Education:
London School of Economics
Boston University School of Law
Qin Jiang Photo 3

Qin Jiang - Lawyer

View page
ISLN:
924303042
Admitted:
2006

Resumes

Resumes

Qin Jiang Photo 4

Qin Jiang

View page
Location:
New York, NY
Industry:
Civil Engineering
Work:
Ubs 2013 - 2013
Intern
Columbia University In the City of New York 2013 - 2013
Graduate Student
Tongji University Aug 2008 - Jul 2012
Undergraduate Student
Education:
Columbia University In the City of New York 2012 - 2013
Masters, Construction Management Tongji University 2008 - 2012
Bachelors, Civil Engineering
Skills:
Financial Analysis
Financial Modeling
Risk Assessment
Risk Management
Uncertainty Analysis
Mandarin
English
Real Estate
Sustainable Design
Construction Management
Construction Engineering
Civil Design
Environmental Geology
Qin Jiang Photo 5

Qin Jiang

View page
Qin Jiang Photo 6

Qin Jiang

View page
Work:
Shanghai Meteorological Service
Qin Jiang Photo 7

Qin Jiang

View page
Location:
United States

Publications

Us Patents

Benzodiazepine Derivatives, Compositions, And Methods For Treating Cognitive Impairment

View page
US Patent:
20230107032, Apr 6, 2023
Filed:
Jun 27, 2022
Appl. No.:
17/850144
Inventors:
- Baltimore MD, US
John A. Butera - Clarksburg NJ, US
Jianxing Huang - Bethlehem PA, US
Hemantbhai Patel - Piscataway NJ, US
Qin Jiang - Latham NY, US
Robert Jason Herr - Voorheesville NY, US
Emily Elizabeth Freeman - Voorheesville NY, US
Nicholas James Mayhew - Niskayuna NY, US
International Classification:
C07D 487/14
A61P 25/28
A61P 25/18
A61P 25/16
Abstract:
This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with CNS disorders. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating cognitive impairment associated with CNS disorders in a subject in need or at risk thereof, including age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI, Age-Associated Memory Impairment, Age Related Cognitive Decline, dementia, Alzheimer's Disease (AD), prodromal AD, PTSD, schizophrenia, bipolar disorder, ALS, cancer-therapy-related cognitive impairment, mental retardation, Parkinson's disease, autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating brain cancers (including brain tumors, e.g., medulloblastomas), and cognitive impairment associated therewith.

Benzodiazepine Derivatives, Compositions, And Methods For Treating Cognitive Impairment

View page
US Patent:
20230098667, Mar 30, 2023
Filed:
Dec 18, 2020
Appl. No.:
17/786175
Inventors:
- Baltimore MD, US
John A. Butera - Clarksburg NJ, US
Jianxing Huang - Bethlehem PA, US
Hemantbhai Patel - Piscataway NJ, US
Qin Jiang - Latham NY, US
Robert Jason Herr - Voorheesville NY, US
Emily Elizabeth Freeman - Voorheesville NY, US
Nicholas James Mayhew - Niskayuna NY, US
International Classification:
A61K 31/5517
C07D 487/14
A61K 31/496
A61K 31/5513
A61K 31/13
A61K 31/445
A61K 31/55
A61K 31/27
A61P 25/28
Abstract:
This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with CNS disorders. It also relates to the use of an α5-containing GABAreceptor agonist (e.g, an α5-containing GABAreceptor positive allosteric modulator) in treating cognitive impairment associated with CNS disorders in a subject in need or at risk thereof, including age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI, Age-Associated Memory Impairment, Age Related Cognitive Decline, dementia, Alzheimer's Disease (AD), prodromal AD, PTSD, schizophrenia, bipolar disorder, ALS, cancer-therapy-related cognitive impairment, mental retardation, Parkinson's disease, autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating brain cancers (including brain tumors, e.g., medulloblastomas), and cognitive impairment associated therewith.

Benzodiazepine Derivatives, Compositions, And Methods For Treating Cognitive Impairment

View page
US Patent:
20200048268, Feb 13, 2020
Filed:
Jun 19, 2019
Appl. No.:
16/445854
Inventors:
- Baltimore MD, US
John A. Butera - Clarksburg NJ, US
Jianxing Huang - Bethlehem PA, US
Hemantbhai Patel - Piscataway NJ, US
Qin Jiang - Latham NY, US
Robert Jason Herr - Voorheesville NY, US
Emily Elizabeth Freeman - Voorheesville NY, US
Nicholas James Mayhew - Niskayuna NY, US
International Classification:
C07D 487/14
A61P 25/16
A61P 25/28
A61P 25/18
Abstract:
This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with CNS disorders. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating cognitive impairment associated with CNS disorders in a subject in need or at risk thereof, including age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI, Age-Associated Memory Impairment, Age Related Cognitive Decline, dementia, Alzheimer's Disease (AD), prodromal AD, PTSD, schizophrenia, bipolar disorder, ALS, cancer-therapy-related cognitive impairment, mental retardation, Parkinson's disease, autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating brain cancers (including brain tumors, e.g., medulloblastomas), and cognitive impairment associated therewith.

Wikipedia

Jiang Qin

View page

Jiang Qin (died 219), style name Gongyi (), was a military general serving under the warlord Sun Quan during the late Han Dynasty period of Chinese history.
Control profile
Qin Jiang from Las Cruces, NM, age ~62 Get Report